HERCULES, CA--(Marketwire -08/29/12)- Bio-Rad Laboratories, Inc. (BIO) and (BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today ...
HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...
Bio-Rad Laboratories said today it acquired GnuBIO, in a deal that expands the acquiring company’s droplet-based DNA sequencing technology offerings within its portfolio of clinical diagnostics ...
Hercules, CA -- October 19, 2015 -- Bio-Rad's Droplet Digital PCR (ddPCR™) technology identifies viral RNA mutations in clinical samples with greater precision, sensitivity, and reproducibility than ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its SARS-CoV-2 ...
DENVILLE, N.J. and HERCULES, Calif., Nov. 19, 2019 /PRNewswire-PRWeb/ -- Diagenode, Inc., a leading global provider of solutions for epigenetics research and sample ...
Bio-Rad Laboratories has received FDA clearance for two digital PCR products designed to monitor patients’ molecular responses to tyrosine kinase inhibitor treatments in chronic myeloid leukemia. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results